newsfilter
← Latest News
GlobeNewswire·

Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026

  • Aligos Therapeutics, Inc. (NASDAQ: ALGS) announced it will report fourth quarter 2025 financial results on Thursday, March 5, 2026, before the U.S. financial markets open.
  • The company is a clinical-stage biopharmaceutical firm focused on developing therapies for liver and viral diseases, including chronic HBV, MASH, obesity, and coronaviruses.
  • The press release includes forward-looking statements subject to risks inherent in drug development, clinical trials, and regulatory approval processes.
  • Investors are directed to review Aligos' Form 10-Q filed on November 6, 2025, for a detailed description of potential risks.
  • Contact information for Jordyn Tarazi, Vice President of Investor Relations & Corporate Communications, is provided for media inquiries.